Nathan Shankar, PhD

University of Oklahoma HSC
Department of Pharmaceutical Sciences
College of Pharmacy CPB-305
Oklahoma City, OK
United States 73117

Any personal financial relationships? No

I have not and will not accept any additional honoraria, payments or reimbursements beyond that which has been agreed upon directly with ICMI.
I agree to provide educational content and resources in advance for review if requested by ICMI.
1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.
2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).
3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.
4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".

Signed on 02/07/2015 by Nathan Shankar
Papers:
F.7 Critical Role of MyD88 in Phagocytosis and Cell Signaling During E. faecalis Infection of Macrophages